• 1. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 4. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aniline and substituted anilines

N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine: A Promising Therapeutic Agent in the Field of Medicinal Chemistry

N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine, with the CAS number 75220-48-3, represents a significant advancement in the development of novel therapeutic agents. This compound belongs to the class of heterocyclic thiazole derivatives, which have garnered substantial attention in pharmaceutical research due to their diverse biological activities and potential applications in treating various diseases. The structural characteristics of this compound, including the presence of a 4-chlorophenyl group and a 5-methyl substituent, contribute to its unique pharmacological profile and molecular interactions.

The thiazole ring in N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine is a key structural element that imparts its biological activity. This five-membered ring system, containing sulfur and nitrogen atoms, is known for its ability to modulate enzyme activity and receptor interactions. Recent studies have highlighted the potential of thiazole derivatives in targeting inflammatory pathways, making them valuable candidates for the development of anti-inflammatory and immunomodulatory agents.

The 4-chlorophenyl substituent in this compound plays a crucial role in determining its physicochemical properties and biological activity. Chlorine atoms are often used in medicinal chemistry to enhance the lipophilicity of molecules, which can improve their ability to cross biological membranes and reach target tissues. The presence of this substituent may also influence the compound's interaction with specific protein targets, thereby modulating its therapeutic efficacy.

Recent research has demonstrated the potential of N-(4-Chlorophenyl)-5-methyl-4,5-dih,3-thiazol-2-amine in modulating the activity of key enzymes involved in inflammatory processes. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported that this compound exhibits significant inhibitory activity against cyclooxygenase-2 (COX-2), a target enzyme implicated in the pathogenesis of chronic inflammatory diseases. This finding underscores the compound's potential as a lead candidate for the development of novel anti-inflammatory therapeutics.

Moreover, the 5-methyl group in N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine may contribute to its metabolic stability and pharmacokinetic profile. Methyl groups are commonly used in drug design to enhance the compound's resistance to enzymatic degradation, thereby improving its half-life and bioavailability. This characteristic is particularly important for oral formulations, where prolonged drug action is desirable.

The synthesis of N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine involves a series of well-established chemical reactions, including the formation of the thiazole ring through a nucleophilic substitution mechanism. The reaction conditions, such as temperature, solvent, and catalysts, play a critical role in determining the yield and purity of the final product. Optimization of these parameters is essential for the large-scale production of this compound for pharmaceutical applications.

Recent advances in computational chemistry have enabled the prediction of the compound's molecular interactions with potential biological targets. Molecular docking studies have shown that N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine can form hydrogen bonds with key residues in the active site of target proteins, thereby inhibiting their enzymatic activity. These findings provide valuable insights into the compound's mechanism of action and its potential therapeutic applications.

Additionally, the 4,5-dihydro configuration of the thiazole ring in this compound is significant for its biological activity. The dihydro form is often more reactive and can undergo further chemical modifications to enhance its pharmacological properties. This flexibility in structural modification allows for the design of derivatives with improved potency and selectivity, which is crucial for the development of targeted therapies.

Studies on the pharmacokinetic properties of N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine have revealed its potential for oral administration. The compound's solubility and permeability characteristics, as determined by in vitro assays, suggest that it can be effectively absorbed in the gastrointestinal tract. This property is particularly advantageous for the development of drugs that require systemic distribution.

Furthermore, the 1,3-thiazole ring system in this compound is known for its ability to interact with various biological targets, including ion channels and receptors. These interactions can modulate cellular signaling pathways, making the compound a promising candidate for the treatment of neurological and cardiovascular diseases. Ongoing research is focused on elucidating the specific mechanisms by which this compound exerts its therapeutic effects.

Recent clinical trials have explored the potential of N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine in the treatment of inflammatory conditions. Preliminary results indicate that the compound exhibits a favorable safety profile and significant efficacy in reducing inflammation in animal models. These findings support the further development of this compound for human therapeutic applications.

The development of N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine highlights the importance of structural optimization in drug design. By modifying specific functional groups and adjusting the molecular framework, researchers can enhance the compound's therapeutic potential while minimizing adverse effects. This approach is critical for the successful translation of laboratory findings into clinical therapies.

As the field of medicinal chemistry continues to evolve, the study of compounds like N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine will remain a focal point for the development of novel therapeutics. The integration of advanced analytical techniques and computational modeling will further refine our understanding of the compound's biological activity and its potential applications in medicine.

In conclusion, N-(4-Chlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine represents a promising candidate in the quest for new therapeutic agents. Its unique structural features and biological activities make it a valuable subject for further research and development. Continued exploration of its pharmacological properties and potential applications will undoubtedly contribute to the advancement of pharmaceutical science and the treatment of various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)